Maria Carmela Pera

Revised upper limb module for spinal muscular atrophy: Development of a new module

Elena Mazzone, Anna Mayhew, Jacqueline Montes et al. · Muscle & Nerve · 2016 · 342 citations

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial

Eugenio Mercuri, Francesco Muntoni, Giovanni Baranello et al. · The Lancet Neurology · 2021 · 237 citations

Gene Therapies, Clinical Trials, Neurology +2

Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials

Eugenio Mercuri, Richard S. Finkel, Jacqueline Montes et al. · Neuromuscular Disorders · 2015 · 212 citations · Full text

Disease Progression, Clinical Epidemiology, Chronic Disease +9

Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy

Maria Carmela Pera, Giorgia Coratti, Nicola Forcina et al. · BMC Neurology · 2017 · 209 citations · Full text

Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool

Danielle Ramsey, Mariacristina Scoto, Anna Mayhew et al. · PLoS ONE · 2017 · 157 citations · Full text

Neurological Rehabilitation, Spinal Disorder, Orthopaedic Surgery +17